C J Cockerell|J B Howell|C M Balch - JoVE Visualize

Showing results (241-250 of 264) with videos related to

Pageof 27

Sort By:

American Journal of Otolaryngology|March 10, 2015

Multidisciplinary treatment of olfactory neuroblastoma: Patterns of failure and management of recurrenceG J Petruzzelli, J B Howell, A Pederson, et al.

Annals of Surgery|December 1, 1984

Head and neck melanoma in 534 clinical Stage I patients. A prognostic factors analysis and results of surgical treatmentM M Urist, C M Balch, S J Soong, et al.

Cancer Treatment Reviews|June 1, 1989

Interleukin-2 alone and in combination with other cytokines in melanoma: the investigational approach at the University of Texas M.D. Anderson Cancer CenterD R Parkinson, M Talpaz, K H Lee, et al.

American Journal of Surgery|October 17, 1998

Prospective, randomized, double-blind study of prophylactic antibiotics in axillary lymph node dissectionR J Bold, P F Mansfield, D H Berger, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2001

Sentinel lymph node biopsy for melanoma: controversy despite widespread agreementK M McMasters, D S Reintgen, M I Ross, et al.

In Vivo (Athens, Greece)|November 1, 1991

Immunological properties of melanoma tumor-infiltrating lymphocytes before and after IL-2-based biotherapiesK Itoh, C M Balch, J L Murray, et al.

Annals of Surgical Oncology|January 5, 2002

Improved staging of node-negative patients with intermediate to thick melanomas (>1 mm) with the use of lymphatic mapping and sentinel lymph node biopsyS Dessureault, S J Soong, M I Ross, et al.

Annals of Surgery|September 1, 1993

Efficacy of 2-cm surgical margins for intermediate-thickness melanomas (1 to 4 mm). Results of a multi-institutional randomized surgical trialC M Balch, M M Urist, C P Karakousis, et al.

Cancer|January 1, 1995

A phase III randomized, double-blind multiinstitutional trial of vaccinia melanoma oncolysate-active specific immunotherapy for patients with stage II melanomaM K Wallack, M Sivanandham, C M Balch, et al.

Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|October 1, 1991

Study of tumor-infiltrating lymphocytes for adoptive therapy of renal cell carcinoma (RCC) and metastatic melanoma: sequential proliferation of cytotoxic natural killer and noncytotoxic T cells in RCCK Hayakawa, M A Salmeron, D R Parkinson, et al.

Pageof 27

Showing results (241-250 of 264) with videos related to

Sort By:

Pageof 27

American Journal of Otolaryngology|March 10, 2015

Multidisciplinary treatment of olfactory neuroblastoma: Patterns of failure and management of recurrenceG J Petruzzelli, J B Howell, A Pederson, et al.

Annals of Surgery|December 1, 1984

Head and neck melanoma in 534 clinical Stage I patients. A prognostic factors analysis and results of surgical treatmentM M Urist, C M Balch, S J Soong, et al.

Cancer Treatment Reviews|June 1, 1989

Interleukin-2 alone and in combination with other cytokines in melanoma: the investigational approach at the University of Texas M.D. Anderson Cancer CenterD R Parkinson, M Talpaz, K H Lee, et al.

American Journal of Surgery|October 17, 1998

Prospective, randomized, double-blind study of prophylactic antibiotics in axillary lymph node dissectionR J Bold, P F Mansfield, D H Berger, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2001

Sentinel lymph node biopsy for melanoma: controversy despite widespread agreementK M McMasters, D S Reintgen, M I Ross, et al.

In Vivo (Athens, Greece)|November 1, 1991

Immunological properties of melanoma tumor-infiltrating lymphocytes before and after IL-2-based biotherapiesK Itoh, C M Balch, J L Murray, et al.

Annals of Surgical Oncology|January 5, 2002

Improved staging of node-negative patients with intermediate to thick melanomas (>1 mm) with the use of lymphatic mapping and sentinel lymph node biopsyS Dessureault, S J Soong, M I Ross, et al.

Annals of Surgery|September 1, 1993

Efficacy of 2-cm surgical margins for intermediate-thickness melanomas (1 to 4 mm). Results of a multi-institutional randomized surgical trialC M Balch, M M Urist, C P Karakousis, et al.

Cancer|January 1, 1995

A phase III randomized, double-blind multiinstitutional trial of vaccinia melanoma oncolysate-active specific immunotherapy for patients with stage II melanomaM K Wallack, M Sivanandham, C M Balch, et al.

Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|October 1, 1991

Study of tumor-infiltrating lymphocytes for adoptive therapy of renal cell carcinoma (RCC) and metastatic melanoma: sequential proliferation of cytotoxic natural killer and noncytotoxic T cells in RCCK Hayakawa, M A Salmeron, D R Parkinson, et al.

Pageof 27